Connection

DAVID CORRY to Middle Aged

This is a "connection" page, showing publications DAVID CORRY has written about Middle Aged.
Connection Strength

0.242
  1. Benefits of antifungal therapy in asthma patients with airway mycosis: A retrospective cohort analysis. Immun Inflamm Dis. 2018 06; 6(2):264-275.
    View in: PubMed
    Score: 0.033
  2. Empiric azithromycin alters the upper respiratory microbiome and resistome without anti-inflammatory benefit in COVID-19. Nat Microbiol. 2026 Apr; 11(4):1100-1112.
    View in: PubMed
    Score: 0.014
  3. Evaluating COVID-19 severity prediction and immune dynamics with NULISAseq: Insights from the IMPACC study. J Immunol. 2025 Dec 01; 214(12):3310-3320.
    View in: PubMed
    Score: 0.014
  4. Utilization of Intensive Care Interventions in Critically Ill Patients With Candidemia Versus Bacteremia: A Multicenter Retrospective Cohort Study. Crit Care Med. 2026 02 01; 54(2):246-256.
    View in: PubMed
    Score: 0.014
  5. Circulating endothelial signatures correlate with worse outcomes in COVID-19, respiratory failure and ARDS. Crit Care. 2025 Oct 14; 29(1):432.
    View in: PubMed
    Score: 0.014
  6. Lung NR3C1+ and CXCR6high T cells distinguish immunopathogenesis of human emphysema. Commun Biol. 2025 Sep 24; 8(1):1353.
    View in: PubMed
    Score: 0.014
  7. A multiomics recovery factor predicts long COVID in the IMPACC study. J Clin Invest. 2025 Nov 03; 135(21).
    View in: PubMed
    Score: 0.014
  8. Platelets and mortality in bloodstream infection: a multicenter cohort study. Clin Microbiol Infect. 2025 Oct; 31(10):1733-1736.
    View in: PubMed
    Score: 0.014
  9. MICBG406A polymorphism reduces risk of mechanical ventilation and death during viral acute lung injury. JCI Insight. 2025 08 08; 10(15).
    View in: PubMed
    Score: 0.014
  10. High-affinity CD16A polymorphism associated with reduced risk ofsevere COVID-19. JCI Insight. 2025 Jul 08; 10(13).
    View in: PubMed
    Score: 0.013
  11. Allergic fungal rhinosinusitis linked to other hyper-IgE syndromes through defective TH17 responses. J Allergy Clin Immunol. 2024 Nov; 154(5):1169-1179.
    View in: PubMed
    Score: 0.013
  12. Cigarette smoke-induced reduction of C1q promotes emphysema. JCI Insight. 2019 05 21; 5.
    View in: PubMed
    Score: 0.009
  13. Elastin-Specific Autoimmunity in Smokers With Thoracic Aortic Aneurysm and Dissection is Independent of Chronic Obstructive Pulmonary Disease. J Am Heart Assoc. 2019 04 16; 8(8):e011671.
    View in: PubMed
    Score: 0.009
  14. Aspergillus fumigatus induction of IL-33 expression in chronic rhinosinusitis is PAR2-dependent. Laryngoscope. 2019 10; 129(10):2230-2235.
    View in: PubMed
    Score: 0.009
  15. Cell mediated immune responses following revaccination with an influenza A/H5N1 vaccine. Vaccine. 2016 Jan 20; 34(4):547-554.
    View in: PubMed
    Score: 0.007
  16. Clinical and Immunological Factors in Emphysema Progression. Five-Year Prospective Longitudinal Exacerbation Study of Chronic Obstructive Pulmonary Disease (LES-COPD). Am J Respir Crit Care Med. 2015 Nov 15; 192(10):1171-8.
    View in: PubMed
    Score: 0.007
  17. Airway surface mycosis in chronic TH2-associated airway disease. J Allergy Clin Immunol. 2014 Aug; 134(2):325-31.
    View in: PubMed
    Score: 0.006
  18. Blocking KV1.3 channels inhibits Th2 lymphocyte function and treats a rat model of asthma. J Biol Chem. 2014 May 02; 289(18):12623-32.
    View in: PubMed
    Score: 0.006
  19. IL-33-responsive innate lymphoid cells are an important source of IL-13 in chronic rhinosinusitis with nasal polyps. Am J Respir Crit Care Med. 2013 Aug 15; 188(4):432-9.
    View in: PubMed
    Score: 0.006
  20. Cross-sectional analysis of the utility of pulmonary function tests in predicting emphysema in ever-smokers. Int J Environ Res Public Health. 2011 05; 8(5):1324-40.
    View in: PubMed
    Score: 0.005
  21. Human rhinovirus proteinase 2A induces TH1 and TH2 immunity in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2010 Jun; 125(6):1369-1378.e2.
    View in: PubMed
    Score: 0.005
  22. An immune basis for lung parenchymal destruction in chronic obstructive pulmonary disease and emphysema. PLoS Med. 2004 Oct; 1(1):e8.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.